Regulation of Human Adipose-derived Stromal Cell Osteogenic Differentiation by Insulin-like Growth Factor-1 and Platelet-derived Growth Factor-alpha
Overview
Authors
Affiliations
Background: Human adipose-derived stromal cells possess a great potential for tissue engineering purposes. The authors' laboratory is interested in harnessing human adipose-derived stromal cells for skeletal tissue regeneration and identifying those factors that enhance human adipose-derived stromal cell osteogenic differentiation. The authors hypothesized that insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) would stimulate human adipose-derived stromal cell osteogenesis and that IGF would stimulate adipogenesis.
Methods: Adipose-derived stromal cells were harvested from human lipoaspirate. Previously, a microarray analysis examined gene expression throughout osteogenic differentiation. In a candidate fashion, the authors added recombinant IGF-1 and PDGF-alpha individually and in combination. Osteogenesis and adipogenesis were assessed by alkaline phosphatase, alizarin red, and oil red O staining, and quantitative real-time polymerase chain reaction (RUNX2, ALP, OCN, IGF1, PPARG, LPL, AP2, and GCP1). Finally, intersection between IGF and PDGF signaling pathways was evaluated.
Results: IGF-1 was observed to increase osteogenic differentiation by all markers (p < 0.01). However, PDGF-alpha when added alone primarily did not affect osteogenic markers. PDGF-alpha positively regulated transcription of IGF1. Addition of PDGF-alpha in combination with or before IGF-1 enhanced osteogenesis more than either alone. IGF-1 increased whereas PDGF-alpha diminished human adipose-derived stromal cell adipogenesis.
Conclusions: IGF signaling significantly increased osteogenesis in human adipose-derived stromal cells and may be used for tissue-engineering purposes. The combination of PDGF and IGF may be more beneficial than either alone in driving adipose-derived stromal cell osteogenesis. Future in vivo applications will focus on the combination of adipose-derived stromal cells, biomimetic scaffolds, and recombinant IGF.
Hemmati S, Maghami P, Ranjbari J, Tabarzad M Protein Pept Lett. 2024; 31(6):469-478.
PMID: 38963110 DOI: 10.2174/0109298665314267240624091046.
Peng Y, Jiang H, Zuo H World J Stem Cells. 2023; 15(6):548-560.
PMID: 37424946 PMC: 10324504. DOI: 10.4252/wjsc.v15.i6.548.
Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance.
Alonso-Perez A, Guillan-Fresco M, Franco-Trepat E, Jorge-Mora A, Lopez-Fagundez M, Pazos-Perez A Biomedicines. 2023; 11(1).
PMID: 36672539 PMC: 9855576. DOI: 10.3390/biomedicines11010031.
Gorji M, Ghasemi N, Setayeshmehr M, Zargar A, Kazemi M, Soleimani M Adv Biomed Res. 2020; 9:6.
PMID: 32181230 PMC: 7059457. DOI: 10.4103/abr.abr_143_19.
Combining Smoothened Agonist and NEL-Like Protein-1 Enhances Bone Healing.
Lee S, Wang C, Pan H, Shrestha S, Meyers C, Ding C Plast Reconstr Surg. 2017; 139(6):1385-1396.
PMID: 28198775 PMC: 5443697. DOI: 10.1097/PRS.0000000000003367.